• Je něco špatně v tomto záznamu ?

Preferential binding of IFI16 protein to cruciform structure and superhelical DNA

V. Brázda, J. Coufal, JC. Liao, CH. Arrowsmith

. 2012 ; 422 (4) : 716-720.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12034483

Interferon (IFN)-inducible HIN-200 proteins play an important role in transcriptional regulation linked to cell cycle control, inflammation, autoimmunity and differentiation. IFI16 has been identified as a target of IFNα and γ and is a member of the HIN-200 protein family. Expression level of IFI16 is often decreased in breast cancers, implicating its role as a tumor suppressor. As a potent transcription factor, IFI16 possesses a transcriptional regulatory region, a PYD/DAPIN/PAAD region which associates with IFN response, DNA-binding domains and binding regions for tumor suppressor proteins BRCA1 and p53. It is also reported that IFI16 protein is capable of binding p53 and cMYC gene promoters. Here, we demonstrate that IFI16 protein binds strongly to negatively superhelical plasmid DNA at a native superhelix density, as evidenced by electrophoretic retardation of supercoiled (sc) DNA in agarose gels. Binding of IFI16 to supercoiled DNA results in the appearance of one or more retarded DNA bands on the gels. After removal of IFI16, the original mobility of the scDNA is recovered. By contrast, IFI16 protein binds very weakly to the same DNA in linear state. Using short oligonucleotide targets, we also detect a strong preference for IFI16 binding to cruciform DNA structure compared to linear DNA topology. Hence, this novel DNA-binding property of IFI16 protein to scDNA and cruciform structures may play critical roles in its tumor suppressor function.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034483
003      
CZ-PrNML
005      
20160602161328.0
007      
ta
008      
121023s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bbrc.2012.05.065 $2 doi
035    __
$a (PubMed)22618232
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brázda, Václav, $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic. vaclav@ibp.cz $d 1970- $7 nlk20010096077
245    10
$a Preferential binding of IFI16 protein to cruciform structure and superhelical DNA / $c V. Brázda, J. Coufal, JC. Liao, CH. Arrowsmith
520    9_
$a Interferon (IFN)-inducible HIN-200 proteins play an important role in transcriptional regulation linked to cell cycle control, inflammation, autoimmunity and differentiation. IFI16 has been identified as a target of IFNα and γ and is a member of the HIN-200 protein family. Expression level of IFI16 is often decreased in breast cancers, implicating its role as a tumor suppressor. As a potent transcription factor, IFI16 possesses a transcriptional regulatory region, a PYD/DAPIN/PAAD region which associates with IFN response, DNA-binding domains and binding regions for tumor suppressor proteins BRCA1 and p53. It is also reported that IFI16 protein is capable of binding p53 and cMYC gene promoters. Here, we demonstrate that IFI16 protein binds strongly to negatively superhelical plasmid DNA at a native superhelix density, as evidenced by electrophoretic retardation of supercoiled (sc) DNA in agarose gels. Binding of IFI16 to supercoiled DNA results in the appearance of one or more retarded DNA bands on the gels. After removal of IFI16, the original mobility of the scDNA is recovered. By contrast, IFI16 protein binds very weakly to the same DNA in linear state. Using short oligonucleotide targets, we also detect a strong preference for IFI16 binding to cruciform DNA structure compared to linear DNA topology. Hence, this novel DNA-binding property of IFI16 protein to scDNA and cruciform structures may play critical roles in its tumor suppressor function.
650    _2
$a křížová struktura DNA $x chemie $x metabolismus $7 D045566
650    _2
$a superhelikální DNA $x chemie $x metabolismus $7 D004278
650    _2
$a lidé $7 D006801
650    _2
$a nádory $x genetika $x metabolismus $7 D009369
650    _2
$a jaderné proteiny $x metabolismus $7 D009687
650    _2
$a konformace nukleové kyseliny $7 D009690
650    _2
$a fosfoproteiny $x metabolismus $7 D010750
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Coufal, Jan $7 _AN073529 $u nstitute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic
700    1_
$a Liao, Jack C C. $u Campbell Family Cancer Research Institute, Department of Medical Biophysics, Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada M5G 1L7
700    1_
$a Arrowsmith, Cheryl H. $u Campbell Family Cancer Research Institute, Department of Medical Biophysics, Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada M5G 1L7 $7 gn_A_00008896
773    0_
$w MED00009307 $t Biochemical and biophysical research communications $x 1090-2104 $g Roč. 422, č. 4 (2012), s. 716-720
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22618232 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20160602161103 $b ABA008
999    __
$a ok $b bmc $g 956493 $s 791980
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 422 $c 4 $d 716-720 $i 1090-2104 $m Biochemical and biophysical research communications $n Biochem Biophys Res Commun $x MED00009307
LZP    __
$b NLK112 $a Pubmed-20121023

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...